Brand Name
Horizant
Generic Name
Gabapentin Enacarbil
View Brand Information FDA approval date: May 01, 2013
Form: Tablet
What is Horizant (Gabapentin Enacarbil)?
HORIZANT is indicated for: treatment of moderate-to-severe primary Restless Legs Syndrome in adults.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
Summary: Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation. The investigators propose a clinical trial to better elucidate whether a sleep disorder, restless legs syndrome, may be a mechanis...

